Evidence map›Paper›PMID 37176611›Full record

ArticleJournal of clinical medicine2023

A Novel Constitutional t(3;8)(p26;q21) and

Viviane Lamim Lovatel, Ana Paula Bueno, Elaiza Almeida Antônio de Kós, Laura Guimarães Corrêa Meyer, Gerson Moura Ferreira, Mayara de Fátima Kalonji, Fabiana Vieira de Mello, Cristiane Bedran Milito, Elaine Sobral da Costa, Eliana Abdelhay and 3 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. GermlineCancer genomics & proteomics
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Viviane Lamim LovatelCytogenetic Laboratory, Cell and Gene Therapy Program, Instituto Nacional do Câncer (INCA), Rio de Janeiro 20230-130, Brazil.ORCID 0000-0001-8493-5855
Ana Paula BuenoInstituto de Puericultura e Pediatria Martagão Gesteira, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.
Elaiza Almeida Antônio de KósCytogenetic Laboratory, Cell and Gene Therapy Program, Instituto Nacional do Câncer (INCA), Rio de Janeiro 20230-130, Brazil.
Laura Guimarães Corrêa MeyerOutpatient Department, Bone Marrow Transplantation Center, Instituto Nacional de Câncer, Rio de Janeiro 20230-130, Brazil.
Gerson Moura FerreiraStem Cell Laboratory, Bone Marrow Transplantation Center, Instituto Nacional de Câncer, Rio de Janeiro 20230-130, Brazil.ORCID 0000-0002-3467-2580
Mayara de Fátima KalonjiInstituto de Puericultura e Pediatria Martagão Gesteira, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.
Fabiana Vieira de MelloInstituto de Puericultura e Pediatria Martagão Gesteira, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.ORCID 0000-0003-0303-3468
Cristiane Bedran MilitoPathology Department, Federal University of Rio de Janeiro, Rio de Janeiro 21941-599, Brazil.
Elaine Sobral da CostaInstituto de Puericultura e Pediatria Martagão Gesteira, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.ORCID 0000-0002-5340-5816
Eliana AbdelhayStem Cell Laboratory, Bone Marrow Transplantation Center, Instituto Nacional de Câncer, Rio de Janeiro 20230-130, Brazil.
Maria Dolores Tabernero RedondoInstituto de Investigación Biomédica de Salamanca (IBSAL), 37007 Salamanca, Spain.ORCID 0000-0002-4430-9806
Maria S Pombo-de-OliveiraResearch Centre, Instituto Nacional de Câncer (INCA), Rio de Janeiro 20231-050, Brazil.ORCID 0000-0002-1507-004X
Teresa de Souza FernandezCytogenetic Laboratory, Cell and Gene Therapy Program, Instituto Nacional do Câncer (INCA), Rio de Janeiro 20230-130, Brazil.ORCID 0000-0003-1299-4666
Instituto Nacional de Câncer - INCA · BRUniversidade Federal do Rio de Janeiro · BRInstituto de Investigación Biomédica de Salamanca · ES

Funding

Lacrimal Gland Repair Using Progenitor CellsR01EY026202 · NEI · SCRIPPS RESEARCH INSTITUTE, THE · PI MAKARENKOVA, HELEN P. · 2016 to 2025
$5.2M
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro FAPERJ/E-26/201.036/2022Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro FAPERJ/E-26/201.218/2022Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro FAPERJ//E-26/202.577/2019National Council for Scientific and Technological Development CNPq # 310877/2019-9
6 · The paper itself

Abstract

backgroundChildhood myelodysplastic neoplasm (cMDS) often raises concerns about an underlying germline predisposition, and its verification is necessary to guide therapeutic choice and allow family counseling. Here, we report a novel constitutional t(3;8)(p26;q21) in a child with MDS, inherited from the father, the CASE PRESENTATION: A 4-year-old girl showed repeated infections and severe neutropenia. Bone marrow presented hypocellularity with dysplastic features. The patient had a t(3;8)(p26;q21)c identified by G-banding and FISH analysis. The family nucleus investigation identified the paternal origin of the chromosomal translocation. The NGS study identified

conclusionThis study shows for the first time, cytogenetic and genomic abnormalities inherited from the father and mother, respectively, and their clinical implications. It also shows the importance of investigating patients with constitutional cytogenetic alterations and/or germline variants to provide information to their family nucleus for genetic counseling and understanding of the pathogenesis of childhood MDS.

Indexed as

childhood myelodysplastic neoplasmconstitutional cytogenetic abnormalitygenetic variants

Identifiers

PMID37176611
PMCPMC10179081
OpenAlexW4367298194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.